A phase separation-fortified bi-specific adaptor for conditional tumor killing

Yuyan Liu1, Yuting Zhu1, Weifan Xu2

  • 1State Key Laboratory of Membrane Biology, Frontier Research Center for Biological Structure, Tsinghua University-Peking University Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, 100084, China.

PubMed
Summary

Researchers developed novel phase-separated Tumor Killers (psTK) that use liquid-liquid phase separation (LLPS) to cluster receptors and induce potent tumor cell apoptosis. This approach offers a new strategy for targeted cancer therapy.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K